Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence.
Andrew S P SharpKhoa N CaoMurray D EslerDavid E KandzariMelvin D LoboRoland Erich SchmiederJan B PietzschPublished in: European heart journal. Quality of care & clinical outcomes (2024)
Catheter-based radiofrequency RDN can be a cost-effective strategy for uncontrolled hypertension in the UK, with an ICER substantially below the NICE cost-effectiveness threshold. Funding: Medtronic Inc.